Delgado et al., 1995 - Google Patents
Evaluation of an enzyme-linked immunosorbent assay for the detection of sheep infected and vaccinated with Brucella melitensisDelgado et al., 1995
View PDF- Document ID
- 3097195326946847261
- Author
- Delgado S
- Fernández M
- Cármenes P
- Publication year
- Publication venue
- Journal of Veterinary Diagnostic Investigation
External Links
Snippet
An indirect enzyme-linked immunosorbent assay (ELISA), using the lipopolysaccharide of the cell wall as an antigen, was used to detect Brucella melitensis antibodies in ovine serum. The test was carried out on 703 samples of field serums, which were also analyzed by the …
- 238000002965 ELISA 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weynants et al. | Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production | |
Kurtz et al. | Astrovirus gastroenteritis age distribution of antibody | |
Jacques et al. | Efficacy of ELISA compared to conventional tests (RBPT and CFT) for the diagnosis of Brucella melitensis infection in sheep | |
Perrin et al. | The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus | |
Salih-Alj Debbarh et al. | Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev. 1-vaccinated sheep | |
Roffe et al. | Brucellosis in Yellowstone National Park bison: quantitative serology and infection | |
Olsen et al. | Experimental use of a dot-blot assay to measure serologic responses of cattle vaccinated with Brucella abortus strain RB51 | |
Kittelberger et al. | Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0: 9 II the use of Yersinia outer proteins for the specific detection of Yersinia enterocolitica infections in ruminants | |
Olsen et al. | Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51 | |
Roop II et al. | Experimental infection of goat fetuses in utero with a stable, rough mutant of Brucella abortus | |
Delgado et al. | Evaluation of an enzyme-linked immunosorbent assay for the detection of sheep infected and vaccinated with Brucella melitensis | |
Ikeda et al. | Bovine vaginal antibody responses to immunoaffinity-purified surface antigen of Tritrichomonas foetus | |
Lind et al. | Response to repeated inoculations with Ascaris suum eggs in pigs during the fattening period: II. Specific IgA, IgG, and IgM antibodies determined by enzyme-linked immunosorbent assay | |
Malik et al. | Toxoplasmosis in sheep in northeastern United States | |
TAJIMA et al. | Application of enzyme-linked immunosorbent assay for the seroepizootiological survey of antibodies against porcine cytomegalovirus | |
Abalos et al. | Evaluation of three Brucella soluble antigens used in an indirect ELISA to discriminate S19 vaccinated from naturally infected cattle | |
Holman et al. | Case report: field-acquired subclinical Babesia equi infection confirmed by in vitro culture | |
Amanfu et al. | Field validation of a competitive enzyme-linked immunosorbent assay (cELISA) for the detection of contagious bovine pleuropneumonia in Botswana | |
YOKOMIZO et al. | Evaluation of enzyme-linked immunosorbent assay in comparison with complement fixation test for the diagnosis of subclinical paratuberculosis in cattle | |
Mammerickx et al. | The diagnosis of enzootic bovine leukosis | |
Gray et al. | Immunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipients | |
Sirisinha et al. | Immunological analysis of Opisthorchis and Clonorchis antigens | |
CN102435732A (en) | Toxoplasma IgM antibody immunoblotting kit and preparation method thereof | |
Muvavarirwa et al. | Detection of bovine-virus-diarrhoea-virus antibodies in cattle with an enzyme-linked immunosorbent assay | |
Aaberge et al. | Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors |